McManus Matthew 4
4 · BIO-TECHNE Corp · Filed Feb 4, 2025
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
McManus Matthew
President - Diag & Spatial Bio
Transactions
- Exercise/Conversion
Common Stock
2025-02-01+4,620→ 4,620 total - Exercise/Conversion
Restricted Stock Units
2025-02-01−4,620→ 9,241 total→ Common Stock (4,620 underlying) - Tax Payment
Common Stock
2025-02-01$73.55/sh−1,642$120,769→ 2,978 total
Holdings
- 15,902
Stock Option (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (15,902 underlying) - 15,825
Performance Restricted Stock Units
→ Common Stock (15,825 underlying) - 21,320
Stock Option (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (21,320 underlying) - 2,888
Performance Restricted Stock Units
→ Common Stock (2,888 underlying) - 7,951
Performance Stock Option (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (7,951 underlying) - 7,912
Restricted Stock Units
→ Common Stock (7,912 underlying)
Footnotes (7)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F3]4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
- [F4]Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
- [F5]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F6]2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.
- [F7]Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.